CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSOTTI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 218
NA - Nord America 177
EU - Europa 61
SA - Sud America 30
AF - Africa 8
OC - Oceania 1
Totale 495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 165
CN - Cina 58
SG - Singapore 57
HK - Hong Kong 39
BR - Brasile 15
IQ - Iraq 14
IN - India 13
RU - Federazione Russa 13
IT - Italia 11
DE - Germania 8
FR - Francia 8
AR - Argentina 7
BD - Bangladesh 7
CA - Canada 7
VE - Venezuela 6
VN - Vietnam 5
GB - Regno Unito 4
IE - Irlanda 4
MY - Malesia 4
PH - Filippine 4
LY - Libia 3
NL - Olanda 3
TR - Turchia 3
BG - Bulgaria 2
FI - Finlandia 2
IL - Israele 2
PK - Pakistan 2
SA - Arabia Saudita 2
AU - Australia 1
BB - Barbados 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GD - Grenada 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
MM - Myanmar 1
MX - Messico 1
NP - Nepal 1
SC - Seychelles 1
SE - Svezia 1
SZ - Regno dello Swaziland 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 495
Salva come PNG Salva come JPEG
Città #
San Jose 105
Hong Kong 39
Singapore 39
Council Bluffs 14
Beijing 7
Erbil 7
New Delhi 6
Chandler 5
Moscow 5
New York 5
Rome 5
Ambérieu-en-Bugey 4
Montreal 4
The Dalles 4
Caracas 3
Jacksonville 3
Wilmington 3
Baghdad 2
Belo Horizonte 2
Dallas 2
Dublin 2
Duhok 2
Helsinki 2
Ho Chi Minh City 2
Kajang 2
North Kansas City 2
Santa Clara 2
Tel Aviv 2
Verona 2
Adamantina 1
Almaty 1
Amman 1
Apodaca 1
Ashburn 1
Athens 1
Bari 1
Benghazi 1
Bridgetown 1
Bến Lức 1
Cambridge 1
Carúpano 1
Castelar 1
Cipolletti 1
Clark 1
Cuenca 1
Cumanacoa 1
Dagupan 1
Dalton 1
Denizli 1
Des Moines 1
Dhaka 1
Duque de Caxias 1
Falkenstein 1
Ferrara 1
Fortaleza 1
Frankfurt am Main 1
Frutal 1
Giza 1
Goiânia 1
Haiphong 1
Hanoi 1
Hebei 1
Hyderabad 1
Ismāilābād 1
Izmir 1
Jaipur 1
Jakarta 1
Jeddah 1
Khulna 1
Kingston 1
Kirkuk 1
Kuala Lumpur 1
La Tablada 1
Lapu-Lapu City 1
Lawrence 1
London 1
Ludhiana 1
Lüleburgaz 1
Macapá 1
Makkah 1
Manchester 1
Maracaibo 1
Mascalucia 1
Moreno 1
Munich 1
Nairobi 1
Nampa 1
Navegantes 1
Nazaré Paulista 1
Nueve de Julio 1
Orem 1
Orán 1
Paltan 1
Perth 1
Phnom Penh 1
Piracicaba 1
Posadas 1
Princeton 1
Puchong 1
Qingdao 1
Totale 353
Salva come PNG Salva come JPEG
Nome #
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection 95
Is the rate of virological failure to cART continuing to decline in recent calendar years? 14
A case of chronic bacterial prostatitis due toMycoplasma genitalium 13
Sexually Transmitted Hepatitis (cap. 13) 13
Medical and psychological needs for injectable long-acting cabotegravir as pre-exposure prophylaxis 12
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients 12
Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1 11
Implementation of HIV Pre-exposure Prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE Cohort Survey 11
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 11
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period 10
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy 10
Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 10
Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data 10
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 10
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 10
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 9
The use of intrahepatic portosystemic shunt in HIV positive patients : A retrospective multicentric study 9
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 9
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 8
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 8
A comparison of tenofovir predose concentrations in generic pre-exposure prophylaxis formulations: A short communication 8
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 8
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 8
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy 8
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 7
Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report 7
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 7
Risk factors for community-acquired bacterial meningitis: men who have sex with men (MSM) as a population at risk for meningococcal nasopharyngeal carriage 7
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 7
Outbreak of Acute Hepatitis A involving young men in Lombardy region, Italy: Risk factors, clinical and virological characteristics 7
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 7
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis 7
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 7
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 6
Hepatitis A Virus in men who have sex with men: Need for awareness and vaccination 6
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 6
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation 6
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 6
Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject 6
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 6
Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience 6
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 6
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 6
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 6
Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA) 6
Outbreak of acute hepatitis A involving young men in Lombardy Region, Italy: risk factors, clinical and virological characteristics 6
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 6
Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP 6
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 5
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 5
Feasibility of all-oral anti-HCV treatment during DHAP chemotherapy and autologous stem cell transplantation for T-cell lymphoma 5
Optimizing treatment in HIV/HCV coinfection 5
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study 5
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients 5
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 5
Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV 5
High prevalence of anal papillomavirus infection in men who have sex with men PrEP users 5
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 5
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 4
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 4
Nevirapine-based regimens in routine clinical settings: Results from a large italian cohort of HIV-1 infected adults 3
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 3
Infezioni del fegato e delle vie biliari (cap.12) 3
Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report 3
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 3
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 2
Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results 2
Enterococcus gallinarum endocarditis in a diabetic patient 2
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 2
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 2
Human immunodeficiency virus and hepatitis c virus coinfection: The agenda is full while waiting for new drugs 2
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 2
The burden of liver disease in human immunodeficiency virus-infected patients 1
HIV education and counselling using Facebook: A possible new approach 1
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 1
Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: A casecontrol study 1
A cluster of patients with recombinant B/F HIV-1 infection: Epidemiological, clinical, and virological aspects 1
Electrophysiological Adverse Effects of Direct-Acting Antivirals in Patients With Chronic Hepatitis C 1
Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs 1
Hepatocellular carcinoma in HIV hepatitis C virus 1
Top topics in HCV research arena 1
Clinical management of ESBL-producing Enterobacteriaceae: The insidious role of fluoroquinolones 1
Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy 1
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays 1
FDG-PET/CT imaging in the diagnosis of HIV-associated multicentric castleman disease: Something is still missing 1
Treatment of hepatitis C virus genotype 1-infected patients: Mission accomplished? 1
Totale 581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.202
article - articoli 2.147
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 55
Totale 4.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/20224 0 1 0 0 0 0 0 0 1 0 0 2
2022/202316 1 0 2 1 2 4 1 1 2 0 2 0
2023/20246 0 0 0 2 0 2 1 0 0 0 1 0
2024/202522 1 1 0 3 1 1 0 1 3 0 1 10
2025/2026527 5 2 2 7 13 3 3 1 53 438 0 0
Totale 581